Vienna Hypothermic Oxygenated Machine Perfusion Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Vienna
About this trial
In this observational cohort study data on all patients undergoing liver transplantation after hypothermic oxygenated machine perfusion at Medical University of Vienna will be prospectively recorded. Investigation of short- and long-term outcome in this cohort will be conducted.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients undergoing liver transplantation with the use of hypothermic oxygenated machine perfusion
age ≥ 18 years
Disqualifiers
pregnancy
partial grafts
the anatomical integrity of the liver is not preserved in a way that makes the perfusion of the liver possible
Trial population
Patients listed for and undergoing liver transplantation using a liver graft which was subjected to hypothermic oxygenated machine perfusion
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Incidence of ischemic-type biliary lesions
Non-anastomotic stenosis, post-transplant cholangiopathy
Time frame
Within one year after liver transplantationSecondary outcomes
1
Rate of early allograft dysfunction
Deviation of bilirubin, transaminases or international normalised ratio
Time frame
Evaluated within the first 7 postoperative days2
Rate of primary non-function
Time frame
Evaluated in the immediate postoperative period, specifically within the first postoperative week3
Incidence of re-transplantation
Time frame
Evaluated in the immediate postoperative period, specifically within the first postoperative weekSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov